Article PDF first page preview

First page of Blueprint for a Catalan Apheresis Database Initiative: The Catalan Apheresis Therapeutics Network and Its Role in Supporting Health Administration Planning

The Therapeutic Apheresis Database (AfTerCat) was developed to consolidate and standardize data collection for therapeutic apheresis procedures public and private institutions in Catalonia. It covers procedures performed between 2019 and 2023 in 21 apheresis units, with over 26,000 entries, including plasma treatments, cell therapies, and cytapheresis. Variations in workload across public and private institutions were noted, which affecting resource needs and operational costs. By streamlining manual data collection and planning future automation, the AfTerCat registry aims to provide crucial insights for healthcare administrators in optimizing resource allocation, managing procedure costs, and supporting evidence-based policy decisions. The registry's integration into the Organització Catalana de Trasplantaments' (OCATT) digital transformation initiative highlights its potential to impact health policy through improving data centralization and real-time analysis. This project serves as a foundational step toward efficient health system planning and cost management in the growing field of therapeutic apheresis.

Journal Section:
Letter
This content is only available via PDF.
S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2025